Profit Investment Management LLC Sells 108 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Profit Investment Management LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 10.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 934 shares of the company’s stock after selling 108 shares during the quarter. Profit Investment Management LLC’s holdings in HCA Healthcare were worth $280,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Dixon Mitchell Investment Counsel Inc. boosted its holdings in HCA Healthcare by 29.5% during the 4th quarter. Dixon Mitchell Investment Counsel Inc. now owns 66,557 shares of the company’s stock worth $19,977,000 after acquiring an additional 15,146 shares during the last quarter. ERn Financial LLC raised its stake in HCA Healthcare by 3.4% in the 4th quarter. ERn Financial LLC now owns 1,875 shares of the company’s stock valued at $563,000 after acquiring an additional 61 shares during the period. Pinnacle Bancorp Inc. lifted its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. Peak Financial Advisors LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,122,000. Finally, Park Avenue Securities LLC lifted its holdings in shares of HCA Healthcare by 6.0% in the fourth quarter. Park Avenue Securities LLC now owns 12,707 shares of the company’s stock worth $3,814,000 after buying an additional 719 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $309.26 on Friday. The company has a market capitalization of $78.34 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.03 and a beta of 1.64. The stock has a fifty day moving average of $318.49 and a two-hundred day moving average of $353.11. HCA Healthcare, Inc. has a fifty-two week low of $276.50 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were paid a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s payout ratio is presently 11.85%.

Insider Buying and Selling

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent research reports. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.